Surgical & Medical Instruments & Apparatus · SIC 3841

Mobia Medical, Inc.

MOBI

Watch

Latest revenue

$12.1M

as of 2026-03-31

Latest net income

as of 2026-03-31

Net margin

as of 2026-03-31

Community sentiment

Where do you think MOBI is heading?

1 month
6 months
12 months
5 years
Sign in free to vote and see community sentiment

Keep private notes on MOBI — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to add your own notes

MOBI vs S&P 500 · rebased to 100

(S&P 500 +9.3% / yr) 7.2% total
Compare:
Early cycleMid cycleLate cycleRecession

Background shading marks the US business-cycle phase at each point in time — early, mid and late expansion, then recession— so you can see which economic backdrop each move happened in. Recessions are NBER-official; expansion sub-phases are ActaClear's editorial dating.

Lines:
Overlay:

Live market

delayed ≤15 min
$14.55
11.84%
Market cap
$483.8M
Enterprise value
$435.3M
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$15.29
52-wk low
$10.19
Beta
Shares out
33.2M

What this company does

AI

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations You should read the following management’s discussion and analysis of our financial condition and results of operations in conjunction with our condensed unaudited interim financial statements (the condensed financial statements) and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited financial statements and notes thereto for the year ended December 31, 2025, included in our prospectus dated May 7, 2026, filed with the U.S. Securities and Exchange Commission (SEC) pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the…

AI summary unavailable — showing raw filing excerpt

Generated from MOBI's filing dated 2026-06-04

Key risks

AI

Item 1A. Risk Factors Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information in this Quarterly Report, including our financial statements and the related notes and the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and our other public filings. The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. In such an event, the market price of our common stock could decline and you may lose all or part of your investment. Additional risks and…

AI summary unavailable — showing raw filing excerpt

Generated from MOBI's filing dated 2026-06-04

6.2
of 10

ActaClear Score

Above avg
#64 of 138 in Surgical & Medical Instruments & Apparatus
+0.5 · 23d
Profitability·25%
Growth·15%
Value·20%
2.6
Quality·20%
Momentum·20%
9.8

Computed from 5 years of SEC fundamentals + latest market data, ranked within Surgical & Medical Instruments & Apparatus (138 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 28, 2026.